Form 4 holding
Director
TITAN PHARMACEUTICALS INC
- Security class
- Common Stock
- Shares / value
- 51,021
- Estimated value
- $62,756
- Report date
- 28 Jan 2022
- Price
- $1.23
- Ownership
- By JT Pharma
James R. McNab - Director at TITAN PHARMACEUTICALS INC
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- TTNP
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by James R. McNab since 07 Sep 2025
Reported holdings for James R. McNab in TITAN PHARMACEUTICALS INC
Form 4 holding
Director
TITAN PHARMACEUTICALS INC
- Security class
- Common Stock
- Shares / value
- 1,669
- Estimated value
- $2,053
- Report date
- 28 Jan 2022
- Price
- $1.23
- Ownership
- Direct
Form 4 holding
Director
TITAN PHARMACEUTICALS INC
- Security class
- Option to Purchase Common Stock
- Shares / value
- 10,000
- Estimated value
- Report date
- 05 Jan 2022
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for James R. McNab in TITAN PHARMACEUTICALS INC
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.